These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1030 related items for PubMed ID: 26698320
1. A ten-year surveillance study of carbapenemase-producing Klebsiella pneumoniae in a tertiary care Greek university hospital: predominance of KPC- over VIM- or NDM-producing isolates. Spyropoulou A, Papadimitriou-Olivgeris M, Bartzavali C, Vamvakopoulou S, Marangos M, Spiliopoulou I, Anastassiou ED, Christofidou M. J Med Microbiol; 2016 Mar; 65(3):240-246. PubMed ID: 26698320 [Abstract] [Full Text] [Related]
2. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece. Pournaras S, Protonotariou E, Voulgari E, Kristo I, Dimitroulia E, Vitti D, Tsalidou M, Maniatis AN, Tsakris A, Sofianou D. J Antimicrob Chemother; 2009 Aug; 64(2):348-52. PubMed ID: 19525514 [Abstract] [Full Text] [Related]
3. A Five-year Surveillance of Carbapenemase-producing Klebsiella pneumoniae in a Pediatric Hospital in China Reveals Increased Predominance of NDM-1. Dong F, Lu J, Wang Y, Shi J, Zhen JH, Chu P, Zhen Y, Han SJ, Guo YL, Song WQ. Biomed Environ Sci; 2017 Aug; 30(8):562-569. PubMed ID: 28807096 [Abstract] [Full Text] [Related]
4. Genetic Relatedness of NDM-Producing Klebsiella pneumoniae Co-Occurring VIM, KPC, and OXA-48 Enzymes from Surveillance Cultures from an Intensive Care Unit. Flores C, Bianco K, de Filippis I, Clementino MM, Romão CMCPA. Microb Drug Resist; 2020 Oct; 26(10):1219-1226. PubMed ID: 32283041 [Abstract] [Full Text] [Related]
5. Reversal of carbapenemase-producing Klebsiella pneumoniae epidemiology from blaKPC- to blaVIM-harbouring isolates in a Greek ICU after introduction of ceftazidime/avibactam. Papadimitriou-Olivgeris M, Bartzavali C, Lambropoulou A, Solomou A, Tsiata E, Anastassiou ED, Fligou F, Marangos M, Spiliopoulou I, Christofidou M. J Antimicrob Chemother; 2019 Jul 01; 74(7):2051-2054. PubMed ID: 31002313 [Abstract] [Full Text] [Related]
6. Microbiological and molecular characteristics of carbapenemase-producing Klebsiella pneumoniae endemic in a tertiary Greek hospital during 2004-2010. Zagorianou A, Sianou E, Iosifidis E, Dimou V, Protonotariou E, Miyakis S, Roilides E, Sofianou D. Euro Surveill; 2012 Feb 16; 17(7):. PubMed ID: 22370015 [Abstract] [Full Text] [Related]
7. Hospital outbreak due to a Klebsiella pneumoniae ST147 clonal strain co-producing KPC-2 and VIM-1 carbapenemases in a tertiary teaching hospital in Northern Greece. Protonotariou E, Poulou A, Politi L, Sgouropoulos I, Metallidis S, Kachrimanidou M, Pournaras S, Tsakris A, Skoura L. Int J Antimicrob Agents; 2018 Sep 16; 52(3):331-337. PubMed ID: 29654892 [Abstract] [Full Text] [Related]
8. Molecular characterization of carbapenemase producing Klebsiella pneumoniae strains by multiplex PCR and PFGE methods: The first K.pneumoniae isolates co-producing OXA-48/KPC and KPC/NDM in Turkey. Genç S, Kolaylı F, Özçelik EY. J Infect Chemother; 2022 Feb 16; 28(2):192-198. PubMed ID: 34711509 [Abstract] [Full Text] [Related]
9. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes. Mouloudi E, Protonotariou E, Zagorianou A, Iosifidis E, Karapanagiotou A, Giasnetsova T, Tsioka A, Roilides E, Sofianou D, Gritsi-Gerogianni N. Infect Control Hosp Epidemiol; 2010 Dec 16; 31(12):1250-6. PubMed ID: 20973725 [Abstract] [Full Text] [Related]
10. Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit. Papadimitriou-Olivgeris M, Marangos M, Christofidou M, Fligou F, Bartzavali C, Panteli ES, Vamvakopoulou S, Filos KS, Anastassiou ED. Scand J Infect Dis; 2014 Sep 16; 46(9):642-8. PubMed ID: 25017796 [Abstract] [Full Text] [Related]
13. Clonal replacement of epidemic KPC-producing Klebsiella pneumoniae in a hospital in China. Liang Y, Yin X, Zeng L, Chen S. BMC Infect Dis; 2017 May 23; 17(1):363. PubMed ID: 28535790 [Abstract] [Full Text] [Related]
14. Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Valle d'Aosta region, Italy, shows the emergence of KPC-2 producing Klebsiella pneumoniae clonal complex 101 (ST101 and ST1789). Del Franco M, Paone L, Novati R, Giacomazzi CG, Bagattini M, Galotto C, Montanera PG, Triassi M, Zarrilli R. BMC Microbiol; 2015 Nov 09; 15(1):260. PubMed ID: 26552763 [Abstract] [Full Text] [Related]
17. Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance. Galani I, Nafplioti K, Adamou P, Karaiskos I, Giamarellou H, Souli M, Study Collaborators. BMC Infect Dis; 2019 Feb 15; 19(1):167. PubMed ID: 30770727 [Abstract] [Full Text] [Related]
18. KPC-Producing Klebsiella pneumoniae Isolates in Croatia: A Nationwide Survey. Jelic M, Butic I, Plecko V, Cipris I, Jajic I, Bejuk D, Koscak I, Marinkovic S, Pal MP, Andrasevic AT. Microb Drug Resist; 2016 Dec 15; 22(8):662-667. PubMed ID: 26709956 [Abstract] [Full Text] [Related]
20. Molecular epidemiology and risk factors for colistin- or tigecycline-resistant carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients during a 7-year period. Papadimitriou-Olivgeris M, Bartzavali C, Spyropoulou A, Lambropoulou A, Sioulas N, Vamvakopoulou S, Karpetas G, Spiliopoulou I, Vrettos T, Anastassiou ED, Fligou F, Christofidou M, Marangos M. Diagn Microbiol Infect Dis; 2018 Nov 15; 92(3):235-240. PubMed ID: 30076041 [Abstract] [Full Text] [Related] Page: [Next] [New Search]